Atlas FDA

Implantable System for Remodulin

FDA premarket approval P140032/S074 · decided 2021-08-31

Approval details

PMA number
P140032
Supplement
S074
Supplement type
Normal 180 Day Track No User Fee
Supplement reason
Postapproval Study Protocol
Trade name
Implantable System for Remodulin
Generic name
Pump, infusion, implanted, programmable
Applicant
Medtronic, Inc.
Date received
2021-08-04
Decision date
2021-08-31
Days to decision
27 days
Decision code
APPR
Product code
LKK
Advisory committee
General Hospital
Expedited review
No
Location
Minneapolis, MN
Statement
Approval of Request for Post-Approval Study Termination.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
VitalFlow Set with Balance™ Biosurface (K261335)Medtronic, Inc.2026-07-31
Concerto Versa™ Detachable Coil (K261866)Medtronic, Inc.2026-06-24
Elongated One-Piece Arterial (EOPA) 3D™ Arterial Cannulae (K260195)Medtronic, Inc.2026-04-23
Retrograde Coronary Sinus Perfusion Cannulae (K253203)Medtronic, Inc.2026-02-19
Clearview Intracoronary Shunts (K253998)Medtronic, Inc.2026-01-20
Bio-Medicus Life Support Catheter and Introducer (K251831)Medtronic, Inc.2026-01-15
Concerto Versa™ Detachable Coil (K253511)Medtronic, Inc.2026-01-14
C320LBB Delivery System (C320LBBS45), C320LBB Delivery System (C320LBBS48), C320LBB Delivery System (C320LBBL45), C320LBB Delivery System (C320LBBL48) (K253409)Medtronic, Inc.2025-12-19